FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stefan Grant

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Giuseppe Giaccone; Channa Debruyne; Enriqueta Felip; Paul B Chapman; Stefan C Grant; Michael Millward; Luc Thiberville; Giannicola D'Addario; Corneel Coens; Lisa S Rome; Petr Zatloukal; Oriol Masso; Catherine Legrand
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
Scott A Laurie; Vincent A Miller; Stefan C Grant; Mark G Kris; Kenneth K Ng
Phase I study of green tea extract in patients with advanced lung cancer.
Lee M Krug; Kenneth K Ng; Mark G Kris; Vincent A Miller; William Tong; Robert T Heelan; L Leon; D Leung; J Kelly; Stefan C Grant; Francis M Sirotnak
Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stefan Grant (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Giuseppe Giaccone; Channa Debruyne; Enriqueta Felip; Paul B Chapman; Stefan C Grant; Michael Millward; Luc Thiberville; Giannicola D'Addario; Corneel Coens; Lisa S Rome; Petr Zatloukal; Oriol Masso; Catherine Legrand
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6854-64.
2005: Scott A Laurie; Vincent A Miller; Stefan C Grant; Mark G Kris; Kenneth K Ng
Phase I study of green tea extract in patients with advanced lung cancer.
Cancer chemotherapy and pharmacology 2005;55(1):33-8.
2000: Lee M Krug; Kenneth K Ng; Mark G Kris; Vincent A Miller; William Tong; Robert T Heelan; L Leon; D Leung; J Kelly; Stefan C Grant; Francis M Sirotnak
Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3493-8.
1999: Lee M Krug; Stefan C Grant; Vincent A Miller; Kenneth K Ng; Mark G Kris
Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.
Seminars in oncology 1999;26(5 Suppl 15):55-61.
1999: Maura Dickler; Govind Ragupathi; Nancy X Liu; Cristina Musselli; D J Martino; Vincent A Miller; Mark G Kris; F T Brezicka; Philip O Livingston; Stefan C Grant
Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2773-9.
1999: Kenneth K Ng; Mark G Kris; Robert J Ginsberg; Robert T Heelan; Katherine M W Pisters; Vincent A Miller; Stefan C Grant; Manjit S Bains; Valerie W Rusch; Kenneth E Rosenzweig; N Martini
Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma.
Cancer 1999;86(7):1189-97.
1999: Stefan C Grant; Mark G Kris; Alan N Houghton; Paul B Chapman
Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1319-23.
1999: JR Rigas; Mark G Kris; Vincent A Miller; Katherine M W Pisters; Robert T Heelan; Stefan C Grant; DW Fennelly; T C Chou; Francis M Sirotnak
Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):601-3.
1999: Barbara A Pizzo; Katherine M W Pisters; Vincent A Miller; Stefan C Grant; L Baltzer; L Hinckley; Mark G Kris
Oral cisapride for the control of delayed vomiting following high-dose cisplatin.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1999;7(1):44-6.
1998: Hedy L Kindler; Mark G Kris; I E Smith; Vincent A Miller; Stefan C Grant; J B Krebs; G A Ross; M L Slevin
Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer.
American journal of clinical oncology 1998;21(5):438-41.
1997: Vincent A Miller; Kenneth K Ng; Stefan C Grant; Hedy L Kindler; Barbara Pizzo; Robert T Heelan; R von Roemeling; Mark G Kris
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1269-71.
1997: Mark G Kris; Vincent A Miller; Kenneth K Ng; Stefan C Grant
The development of docetaxel (Taxotere) in non-small cell lung cancer.
Seminars in oncology 1997;24(4 Suppl 14):S14-1-S14-4.
1997: Vincent A Miller; JR Rigas; William P Tong; J R Reid; Katherine M W Pisters; Stefan C Grant; Robert T Heelan; Mark G Kris
Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1997;40(5):415-8.
1996: Katherine M W Pisters; L B Tyson; William Tong; Martin Fleisher; Vincent A Miller; Stefan C Grant; David G Pfister; J R Rigas; C L Densmore; G Krol; Robert T Heelan; Francis M Sirotnak; Joseph R Bertino; Mark G Kris
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(11):1819-24.
1996: Stefan C Grant; L Kostakoglu; Mark G Kris; Samuel D J Yeh; Steven M Larson; Ronald D Finn; H F Oettgen; Nai-Kong V Cheung
Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial.
European journal of nuclear medicine 1996;23(2):145-9.
1995: Vincent A Miller; J R Rigas; Katherine M W Pisters; Stefan C Grant; David G Pfister; Robert T Heelan; Mark G Kris
Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.
American journal of clinical oncology 1995;18(4):303-6.
1995: Vincent A Miller; J R Rigas; Stefan C Grant; Katherine M W Pisters; Mark G Kris
New chemotherapeutic agents for non-small cell lung cancer.
Chest 1995;107(6 Suppl):306S-311S.
1995: Mark G Kris; Katherine M W Pisters; Robert J Ginsberg; J R Rigas; Vincent A Miller; Stefan C Grant; R J Gralla; Robert T Heelan; N Martini
Effectiveness and toxicity of preoperative therapy in stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2).
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 1():S47-57.
1995: P A Francis; Mark G Kris; J R Rigas; Stefan C Grant; Vincent A Miller
Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 1():S163-72.
1995: Vincent A Miller; J R Rigas; P A Francis; Stefan C Grant; Katherine M W Pisters; Venkatraman E Seshan; K Woolley; Robert T Heelan; Mark G Kris
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.
Cancer 1995;75(4):968-72.
1995: Stefan C Grant; Mark G Kris
New antineoplastic agents in lung cancer 1988-1993.
Cancer treatment and research 1995;72():323-47.
1993: Stefan C Grant; Mark G Kris; R J Gralla; R A Clark; L B Tyson
Dose-ranging evaluation of the substituted benzamide dazopride when used as an antiemetic in patients receiving anticancer chemotherapy.
Cancer chemotherapy and pharmacology 1993;31(6):442-4.
1993: Stefan C Grant; Mark G Kris; C W Young; Francis M Sirotnak
Edatrexate, an antifolate with antitumor activity: a review.
Cancer investigation 1993;11(1):36-45.